No Result
View All Result
  • Private Data
  • Membership options
  • Login
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Home FINTECH

Research Grid’s artificial intelligence automates a 3-year Queen Mary clinical trial in seconds

Cisionby Cision
June 4, 2025
Reading Time: 3 mins read
in FINTECH, UK&IRELAND
Share on FacebookShare on Twitter
  • A large heart imaging study previously undertaken at Queen Mary University of London (QMUL) and Barts Health NHS Trust tested Research Grid’s AI.
  • The AI study demonstrated a savings of $1.5 million in data entry, cut a 5% human error rate, and automated over 24 thousand staff hours with automation

NEW YORK and LONDON, June 4, 2025 /PRNewswire/ — A study at Queen Mary University of London (QMUL) has shown that Research Grid’s patented AI engine can automate one of the most time-consuming parts of medical research — data entry.

Research Grid's patented AI shows trailblazing success in clinical trial automation

In a major cardiac imaging trial involving over 600 patients, the AI was able to digitize thousands of pages of patient records in seconds or minutes. This eliminated a 5% human error rate, saved over 24,000 staff hours, and cut data entry costs from $1.5 million to $6,000.

Over 80% of medical research data globally is still entered manually by highly qualified research staff, slowing progress and driving up costs. Research Grid’s patented AI changes that by safely handling complex clinical trial admin of every kind. For example, handwritten text, numbers, images and anonymization while performing quality checks.

“Our AI safely meets today’s research demands,” said Research Grid Founder and CEO, Dr. Amber Hill. “For too long, the clinical research industry has accepted manual back-office processes as the cost of doing research. The success of this trial shows there’s a better way. It’s a critical next step in the company’s goal of admin-free trials to make research faster and more successful for everyone.”

While AI systems have already found a home in industries like finance and insurance, their use in clinical trials has been limited by the complex and sensitive nature of medical records. This QMUL study illustrates that purpose-built AI automation can be introduced safely and effectively in clinical trials, academic research, and a wider variety of use cases.

Professor Anthony Mathur, Study Lead and Centre Lead for the Centre for Cardiovascular Medicine and Devices at Queen Mary’s William Harvey Research Institute, said:

“This technology has the potential to dramatically improve the efficiency and accuracy of how we perform clinical trials and clearly emphasizes the role of digital technologies in supporting research workflows. I look forward to the future of this technology.”

Beyond clinical trials, the AI could help hospitals and healthcare providers digitize years of paper records in seconds, improving patient tracking and care. As healthcare systems face mounting pressure to modernize with limited resources, this successful trial marks a major step forward in making high-quality, scalable “admin-free” research and care a reality.

About Research Grid

Research Grid is the automation engine for admin-free clinical trials. Too many trials fail because of delays, errors, or weak patient engagement caused by legacy software and manual processes. Our mission is to enable faster, more successful clinical trials by engineering smart software that safely automates back-office admin across the full life cycle.

Photo – https://mma.prnewswire.com/media/2703117/Research_Grid_AI_Clinical_Trial_Automation.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/research-grids-artificial-intelligence-automates-a-3-year-queen-mary-clinical-trial-in-seconds-302473130.html

Read the orginal article: undefined

Gateways to Italy

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

by Partner
June 6, 2023

Sign up to our newsletter

SIGN UP

Related Posts

FINTECH

Are Europe’s public markets a no-go for tech companies?

June 5, 2025
UK&IRELAND

London’s Kiin Bio raises €1.9 million to launch their Virtual Scientist Platform for drug discovery

June 5, 2025
UK&IRELAND

EU-Funded Startups Are Powering Europe’s Tech Future

June 5, 2025

ItaHub

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Italy’s SMEs export toward 260 bn euros in 2025

Italy’s SMEs export toward 260 bn euros in 2025

September 9, 2024
With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

April 23, 2024
EU’s AI Act, like previous rules on technology,  looks more defensive than investment-oriented

EU’s AI Act, like previous rules on technology, looks more defensive than investment-oriented

January 9, 2024

Co-sponsor

Premium

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

March 6, 2025
Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

February 10, 2025
Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Venture capital investments top €1.3bn in 208 rounds as of Sep30  in Italy. They were €1.5 in all 2023. The new BeBeez Report

Venture capital investments top €1.3bn in 208 rounds as of Sep30 in Italy. They were €1.5 in all 2023. The new BeBeez Report

October 28, 2024
Next Post

Swiss HealthTech startup Aeon raises €8.2 million to scale its AI preventive health platform

Finnish startup AIATELLA raises €2 million to scale AI-powered cardiovascular imaging tools - aims to prevent 100 million strokes

EdiBeez srl

C.so Italia 22 - 20122 - Milano
C.F. | P.IVA 09375120962
Aut. Trib. Milano n. 102
del 3 aprile 2013

COUNTRY

Italy
Iberia
France
UK&Ireland
Benelux
DACH
Scandinavia&Baltics

CATEGORY

Private Equity
Venture Capital
Private Debt
Distressed Assets
Real Estate
Fintech
Green

PREMIUM

ItaHUB
Legal
Tax
Trend
Report
Insight view

WHO WE ARE

About Us
Media Partnerships
Contact

INFORMATION

Privacy Policy
Terms&Conditions
Cookie Police

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHub
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • Login
  • Cart